Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 1, 2008, Pages 114-122

  Xu, Xiaohua ^a   Wan, Wenhan ^a   Powers, Anthony S ^a   Li, Ji ^a   Ji, Lisa L ^b   Lao, Shunhua ^a   Wilson, Bryan ^a   Erikson, John M ^c   Zhang, John Q ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Exercise; Extracellular matrix; Fibrosis; Infarction; Remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; HEMODYNAMIC PARAMETERS; KINESIOTHERAPY; MALE; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SITTING; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART VENTRICLES; HEMODYNAMICS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; PHYSICAL CONDITIONING, ANIMAL; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

RATTUS;

EID: 37549032785     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.10.004     Document Type: Article

References (45)

1. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
2. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 (2004) 558-564
3. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90 (2002) 520-530
4. Gunasinghe S.K., Ikonomidis J., and Spinale F.G. Contributory role of matrix metalloproteinases in cardiovascular remodeling. Curr Drug Targets Cardiovasc Haematol Disord 1 (2001) 75-91
5. Peterson J.T., Hallak H., Johnson L., Li H., O'Brien P.M., Sliskovic D.R., et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103 (2001) 2303-2309
6. Cleutjens J.P., Kandala J.C., Guarda E., Guntaka R.V., and Weber K.T. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27 (1995) 1281-1292
7. Creemers E.E., Davis J.N., Parkhurst A.M., Leenders P., Dowdy K.B., Hapke E., et al. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 284 (2003) H364-H371
8. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., and Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 82 (1998) 482-495
9. Jayasankar V., Woo Y.J., Bish L.T., Pirolli T.J., Berry M.F., Burdick J., et al. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation 110 (2004) II180-II186
10. Yamagishi H., Kim S., Nishikimi T., Takeuchi K., and Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 25 (1993) 1369-1380
11. Lefroy D.C., Wharton J., Crake T., Knock G.A., Rutherford R.A., Suzuki T., et al. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28 (1996) 429-440
12. Sun Y., Cleutjens J.P., Diaz-Arias A.A., and Weber K.T. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28 (1994) 1423-1432
13. Shephard R.J., and Balady G.J. Exercise as cardiovascular therapy. Circulation 99 (1999) 963-972
14. Orenstein T.L., Parker T.G., Butany J.W., Goodman J.M., Dawood F., Wen W.H., et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 96 (1995) 858-866
15. Jain M., Liao R., Ngoy S., Whittaker P., Apstein C.S., and Eberli F.R. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats. Cardiovasc Res 46 (2000) 66-72
16. Giannuzzi P., Temporelli P.L., Corra U., Gattone M., Giordano A., and Tavazzi L. Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation 96 (1997) 1790-1797
17. Sun Y., Zhang J., Zhang J.Q., and Weber K.T. Renin expression at sites of repair in the infarcted rat heart. J Mol Cell Cardiol 33 (2001) 995-1003
18. Veras-Silva A.S., Mattos K.C., Gava N.S., Brum P.C., Negrao C.E., and Krieger E.M. Low-intensity exercise training decreases cardiac output and hypertension in spontaneously hypertensive rats. Am J Physiol 273 (1997) H2627-H2631
19. Carlson C.L., and Winder W.W. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J Appl Physiol 86 (1999) 669-674
20. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
21. Mulder P., Boujedaini H., Richard V., Henry J.P., Renet S., Munter K., et al. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy. Circulation 106 (2002) 1159-1164
22. Whittaker P., Kloner R.A., Boughner D.R., and Pickering J.G. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89 (1994) 397-410
23. Sun Y., Zhang J.Q., Zhang J., and Ramires F.J. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol 30 (1998) 1559-1569
24. Hochman J.S., and Healy B. Effect of exercise on acute myocardial infarction in rats. J Am Coll Cardiol 7 (1986) 126-132
25. Sullivan M.J., Higginbotham M.B., and Cobb F.R. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 78 (1988) 506-515
26. Coats A.J., Adamopoulos S., Radaelli A., McCance A., Meyer T.E., Bernardi L., et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85 (1992) 2119-2131
27. Creemers E.E., Cleutjens J.P., Smits J.F., and Daemen M.J. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ Res 89 (2001) 201-210
28. Sun Y., Zhang J.Q., Zhang J., and Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135 (2000) 316-323
29. Li H., Simon H., Bocan T.M., and Peterson J.T. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovasc Res 46 (2000) 298-306
30. Xu X., Xu Z., Xu Y., and Cui G. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis 16 (2005) 245-255
31. Webb C.S., Bonnema D.D., Ahmed S.H., Leonardi A.H., McClure C.D., Clark L.L., et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114 (2006) 1020-1027
32. Leor J., Rozen L., Zuloff-Shani A., Feinberg M.S., Amsalem Y., Barbash I.M., et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation 114 (2006) I94-I100
33. Virag J.I., and Murry C.E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 163 (2003) 2433-2440
34. Desmouliere A., Redard M., Darby I., and Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146 (1995) 56-66
35. Ikeuchi M., Tsutsui H., Shiomi T., Matsusaka H., Matsushima S., Wen J., et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 64 (2004) 526-535
36. Fraccarollo D., Galuppo P., Schmidt I., Ertl G., and Bauersachs J. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction. Cardiovasc Res 67 (2005) 97-105
37. Schieffer B., Wirger A., Meybrunn M., Seitz S., Holtz J., Riede U.N., et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89 (1994) 2273-2282
38. Liu J.L., Irvine S., Reid I.A., Patel K.P., and Zucker I.H. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II. Circulation 102 (2000) 1854-1862
39. Pliquett R.U., Cornish K.G., Patel K.P., Schultz H.D., Peuler J.D., and Zucker I.H. Amelioration of depressed cardiopulmonary reflex control of sympathetic nerve activity by short-term exercise training in male rabbits with heart failure. J Appl Physiol 95 (2003) 1883-1888
40. Sun S.Y., Wang W., Zucker I.H., and Schultz H.D. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86 (1999) 1264-1272
41. Kiilavuori K., Toivonen L., Naveri H., and Leinonen H. Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J 16 (1995) 490-495
42. Gao L., Wang W., Liu D., and Zucker I.H. Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115 (2007) 3095-3102
43. Zucker I.H., Patel K.P., Schultz H.D., Li Y.F., Wang W., and Pliquett R.U. Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev 32 (2004) 107-111
44. Townend J.N., al-Ani M., West J.N., Littler W.A., and Coote J.H. Modulation of cardiac autonomic control in humans by angiotensin II. Hypertension 25 (1995) 1270-1275
45. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., Pozzi M., Morganti A., et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96 (1997) 1173-1179